Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 103

1.

Risk assessments for chronic exposure of children and prospective parents to ethylbenzene (CAS No. 100-41-4).

Sweeney LM, Kester JE, Kirman CR, Gentry PR, Banton MI, Bus JS, Gargas ML.

Crit Rev Toxicol. 2015 May 21:1-65. [Epub ahead of print]

PMID:
25997510
2.

Evaluation of submarine atmospheres: effects of carbon monoxide, carbon dioxide and oxygen on general toxicology, neurobehavioral performance, reproduction and development in rats. II. Ninety-day study.

Hardt DJ, James RA, Gut CP Jr, McInturf SM, Sweeney LM, Erickson RP, Gargas ML.

Inhal Toxicol. 2015 Feb;27(3):121-37. doi: 10.3109/08958378.2014.999294. Epub 2015 Feb 17.

PMID:
25687554
3.

Evaluation of submarine atmospheres: effects of carbon monoxide, carbon dioxide and oxygen on general toxicology, neurobehavioral performance, reproduction and development in rats. I. Subacute exposures.

Hardt DJ, James RA, Gut CP Jr, McInturf SM, Sweeney LM, Erickson RP, Gargas ML.

Inhal Toxicol. 2015 Feb;27(2):83-99. doi: 10.3109/08958378.2014.995386.

PMID:
25600219
4.

Screening-level risk assessment for styrene-acrylonitrile (SAN) trimer detected in soil and groundwater.

Kirman CR, Gargas ML, Collins JJ, Rowlands JC.

J Toxicol Environ Health A. 2012;75(21):1280-97. doi: 10.1080/15287394.2012.709441.

5.

Cancer mode of action, weight of evidence, and proposed cancer reference value for hexahydro-1,3,5-trinitro-1,3,5-triazine (RDX).

Sweeney LM, Okolica MR, Gut CP Jr, Gargas ML.

Regul Toxicol Pharmacol. 2012 Nov;64(2):205-24. doi: 10.1016/j.yrtph.2012.07.005. Epub 2012 Jul 25.

PMID:
22841928
6.

Toxicology and carcinogenesis study of styrene-acrylonitrile trimer in F344/N rats (perinatal and postnatal feed studies).

National Toxicology Program.

Natl Toxicol Program Tech Rep Ser. 2012 Jul;(573):1-155.

7.

Assessing the non-cancer risk for RDX (hexahydro-1,3,5-trinitro-1,3,5-triazine) using physiologically based pharmacokinetic (PBPK) modeling.

Sweeney LM, Gut CP Jr, Gargas ML, Reddy G, Williams LR, Johnson MS.

Regul Toxicol Pharmacol. 2012 Feb;62(1):107-14. doi: 10.1016/j.yrtph.2011.12.007. Epub 2011 Dec 14. Review.

PMID:
22197625
8.

1,3-Butadiene: III. Assessing carcinogenic modes of action.

Kirman CR, Albertini RA, Gargas ML.

Crit Rev Toxicol. 2010 Oct;40 Suppl 1:74-92. doi: 10.3109/10408444.2010.507183. Review.

PMID:
20868268
9.

1,3-Butadiene: II. Genotoxicity profile.

Albertini RJ, Carson ML, Kirman CR, Gargas ML.

Crit Rev Toxicol. 2010 Oct;40 Suppl 1:12-73. doi: 10.3109/10408444.2010.507182. Review.

PMID:
20868267
10.

1,3-Butadiene: I. Review of metabolism and the implications to human health risk assessment.

Kirman CR, Albertini RJ, Sweeney LM, Gargas ML.

Crit Rev Toxicol. 2010 Oct;40 Suppl 1:1-11. doi: 10.3109/10408444.2010.507181. Review.

PMID:
20868266
11.

Comment on M.V. Evans and J.C. Caldwell: evaluation of two different metabolic hypotheses for dichloromethane toxicity using physiologically based pharmacokinetic modeling of in vivo gas uptake data exposure in female B6C3F1 mice, Toxicol. Appl. Pharmacol., 244, 280-290, 2010.

Anders MW, Andersen ME, Clewell HJ 3rd, Gargas ML, Guengerich FP, Reitz RH.

Toxicol Appl Pharmacol. 2010 Oct 1;248(1):63-4; author reply 65-7. doi: 10.1016/j.taap.2010.07.012. Epub 2010 Jul 22. No abstract available.

PMID:
20655322
12.

Estimation of safe dietary intake levels of acrylamide for humans.

Tardiff RG, Gargas ML, Kirman CR, Carson ML, Sweeney LM.

Food Chem Toxicol. 2010 Feb;48(2):658-67. doi: 10.1016/j.fct.2009.11.048. Epub 2009 Dec 3.

PMID:
19948203
13.

Development of a physiologically-based toxicokinetic model of acrylamide and glycidamide in rats and humans.

Sweeney LM, Kirman CR, Gargas ML, Carson ML, Tardiff RG.

Food Chem Toxicol. 2010 Feb;48(2):668-85. doi: 10.1016/j.fct.2009.11.049. Epub 2009 Dec 3.

PMID:
19948202
14.

Quantitative risk analysis for N-methyl pyrrolidone using physiologically based pharmacokinetic and benchmark dose modeling.

Poet TS, Kirman CR, Bader M, van Thriel C, Gargas ML, Hinderliter PM.

Toxicol Sci. 2010 Feb;113(2):468-82. doi: 10.1093/toxsci/kfp264. Epub 2009 Oct 29.

15.

Derivation of a drinking water equivalent level (DWEL) related to the maximum contaminant level goal for perfluorooctanoic acid (PFOA), a persistent water soluble compound.

Tardiff RG, Carson ML, Sweeney LM, Kirman CR, Tan YM, Andersen M, Bevan C, Gargas ML.

Food Chem Toxicol. 2009 Oct;47(10):2557-89. doi: 10.1016/j.fct.2009.07.016. Epub 2009 Jul 22.

PMID:
19631249
16.

Derivation of inhalation toxicity reference values for propylene oxide using mode of action analysis: example of a threshold carcinogen.

Sweeney LM, Kirman CR, Albertini RJ, Tan YM, Clewell HJ, Filser JG, Csanády G, Pottenger LH, Banton MI, Graham CJ, Andrews LS, Papciak RJ, Gargas ML.

Crit Rev Toxicol. 2009;39(6):462-86. doi: 10.1080/10408440902837959. Review.

PMID:
19545197
17.

Iodomethane human health risk characterization.

Mileson BE, Sweeney LM, Gargas ML, Kinzell J.

Inhal Toxicol. 2009 May;21(6):583-605. doi: 10.1080/08958370802601627.

PMID:
19519156
18.

Development of a physiologically based pharmacokinetic (PBPK) model for methyl iodide in rats, rabbits, and humans.

Sweeney LM, Kirman CR, Gannon SA, Thrall KD, Gargas ML, Kinzell JH.

Inhal Toxicol. 2009 May;21(6):552-82. doi: 10.1080/08958370802601569.

PMID:
19519155
19.

Evaluation of possible modes of action for acute effects of methyl iodide in laboratory animals.

Kirman CR, Sweeney LM, Gargas ML, Kinzell JH.

Inhal Toxicol. 2009 May;21(6):537-51. doi: 10.1080/08958370802601510.

PMID:
19519154
20.

A real-time methodology to evaluate the nasal absorption of volatile compounds in anesthetized animals.

Thrall KD, Woodstock AD, Soelberg JJ, Gargas ML, Kinzell JH, Corley RA.

Inhal Toxicol. 2009 May;21(6):531-6. doi: 10.1080/08958370802601452.

PMID:
19519153
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk